Physiological pH Molecular Imprinting for Antibody Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current molecular imprinting technologies face challenges in imprinting larger than 1,500 Da molecules due to size, complexity, and conformational structure of templates, and existing methods require aggressive synthesis environments that can denature proteins, limiting the production of stable and robust artificial antibodies for diagnostic devices, especially in low-resource settings.
Innovation Solution
The development of bio-inspired artificial antibodies using molecular imprinted silica particles synthesized at physiological pH, with tetraethyl orthosilicate as the backbone monomer and 3-Aminopropyl triethoxysilane, carboxybutyl 3-Amidepropyl triethoxysilane, and octyl triethoxysilane as active monomers, and carbon black as a visualizing agent, which enhances specific binding sites and stability, allowing for the recognition of macromolecules like West Nile antibodies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If aggressive synthesis environment is used for molecular imprinting, then imprinting process can proceed, but protein template denatures before imprint formation
Solution Approach 1:
The patent changes the synthesis environment parameters from aggressive (organic solvents, extreme pH) to physiological conditions (aqueous buffer, pH 7.4). This allows the protein template to remain stable and functional throughout the imprinting process while still enabling polymer formation. The sol-gel chemistry is specifically adapted to proceed under these milder conditions.
Solution Approach 2:
The patent introduces a sol-gel intermediary system that bridges the gap between mild physiological conditions and effective polymerization. The silane-based sol-gel chemistry acts as a mediator, allowing crosslinking and polymer formation without requiring aggressive conditions that would denature the protein template.
2Productivity
If conventional molecular imprinting is used for large molecules, then imprinting can occur, but size and complexity of template hinder the process
Solution Approach 1:
The patent segments the large antibody template into recognizable epitopes that can be captured by the imprinted polymer. The sol-gel network forms multiple binding sites that collectively recognize different regions of the large molecule, breaking down the complexity into manageable recognition units.
Solution Approach 2:
The patent creates a composite material combining organic protein templates with inorganic sol-gel matrices. This composite structure allows the polymer to accommodate large, complex molecules while maintaining stability and recognition capability. The hybrid nature of the material provides both the flexibility needed for large templates and the rigidity for stable imprints.
3Reliability
If antibodies are used in diagnostic devices, then recognition capability is achieved, but product stability and cold chain requirements are compromised
Solution Approach 1:
The patent creates artificial copies of antibodies through molecular imprinting. The imprinted polymer replicates the recognition capability of natural antibodies without requiring the complex protein structure. These polymer copies are much more stable, can be stored dry for years, and do not require cold chain maintenance while maintaining antigen recognition ability.
Solution Approach 2:
The patent replaces expensive, fragile biological antibodies with inexpensive, robust synthetic polymers. The imprinted particles can be manufactured at any scale, are stable under various conditions, and can be used repeatedly without degradation, eliminating the need for cold storage and reducing overall cost.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in molecularly imprinted polymers with 160% more specific binding sites and 11 times higher fluorescence, demonstrating improved selectivity and stability, enabling effective recognition and binding of West Nile antibodies, and potentially expanding diagnostic capabilities in low-resource areas.
Implementation Method 1
As the backbone monomer, tetraethyl orthosilicate can be used; and as active monomers, 3-Aminopropyl triethoxysilane, carboxybutyl 3-Amidepropyl triethoxysilane, and octyl triethoxysilane can be used.
Implementation Method 2
The resulting molecularly imprinted polymers can be evaluated utilizing HPLC, centrifuge chromatography, spectrophotometry, and confocal microscopy to establish the importance of physiological pH matching during the synthesis process.
Implementation Method 3
As a visualizing agent, carbon black can be added to the sol-gel process, yielding black silica particles.
Implementation Method 4
Methods and systems are disclosed for producing bio-inspired artificial antibodies with molecular imprinted silica particles... Physiological pH matching produced 160% more specific binding sites when compared to non pH matched molecular imprinting.
Data Source
AI summary
Methods and devices for molecular imprinting include a molecular imprinting synthesis and matching a physiological pH of a template utilized in the molecular imprinting synthesis to achieve molecular imprinting. Molecular imprinting can be achieved by matching the physiological pH of the template used in a molecular imprinting synthesis. Furthermore, electrostatic charges can be complementary matched to the template, by obtaining crystallographic data of a protein template. Particularly, positively and negatively charged amino acids can be counted and matched by an oppositely charged monomer. For hydrophobic amino acids, isoleucin, leucin, and valine amino acids are counted. Since not all hydrophobic amino acids are exposed, the hydrophobic amino acid and hydrophobic monomer ratio can be determined experimentally by varying ratios from 1:1 to 1:10.